Formyl peptide receptor agonists as dual action therapeutics for pulmonary hypertension

被引:0
|
作者
Studley, W. [1 ]
机构
[1] Monash Univ, Melbourne, Vic, Australia
基金
澳大利亚国家健康与医学研究理事会;
关键词
D O I
暂无
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
TP 148
引用
收藏
页码:201 / 201
页数:1
相关论文
共 50 条
  • [31] Differential activation of formyl peptide receptor signaling by peptide Ligands
    Bae, YS
    Song, JY
    Kim, Y
    He, R
    Ye, RD
    Kwak, JY
    Suh, PG
    Ryu, SH
    MOLECULAR PHARMACOLOGY, 2003, 64 (04) : 841 - 847
  • [32] Evolution of formyl peptide receptor function in mammals
    Bufe, B.
    Schumann, T.
    Stempel, H.
    Zufall, F.
    CHEMICAL SENSES, 2014, 39 (01) : 90 - 90
  • [33] CLONING OF A HUMAN FORMYL PEPTIDE RECEPTOR GENE
    PEREZ, HD
    HOLMES, R
    KELLY, E
    MCCLARY, J
    ANDREWS, WH
    CLINICAL RESEARCH, 1992, 40 (02): : A352 - A352
  • [34] Formyl peptide receptor 2 and heart disease
    Lupisella, John A.
    Shirude, Pravin S.
    Wurtz, Nicholas R.
    Garcia, Ricardo A.
    SEMINARS IN IMMUNOLOGY, 2022, 59
  • [35] MOLECULAR MODELING OF THE HUMAN FORMYL PEPTIDE RECEPTOR
    DENNY, BJ
    LAMBERT, PA
    POYNER, DR
    BIOCHEMICAL SOCIETY TRANSACTIONS, 1995, 23 (01) : S96 - S96
  • [36] The uncoupled state of the human formyl peptide receptor
    Gilbert, TL
    Prossnitz, ER
    Sklar, LA
    JOURNAL OF RECEPTOR AND SIGNAL TRANSDUCTION RESEARCH, 1999, 19 (1-4): : 327 - 340
  • [37] Current Therapeutics for Pulmonary Arterial Hypertension
    Hsu, Chih-Hsin
    Glassner, Cherylanne
    Hsu, Hsao-Hsun
    Maitland, Mardi Gomberg
    ACTA CARDIOLOGICA SINICA, 2012, 28 (04) : 267 - 278
  • [38] Editorial: Therapeutics in pulmonary arterial hypertension
    Adao, Rui
    Perez-Vizcaino, Francisco
    Redwan, Bassam
    Bras-Silva, Carmen
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2024, 11
  • [39] ENDOTHELIN(B) RECEPTOR AGONISTS PRODUCE PULMONARY VASODILATION IN INTACT NEWBORN LAMBS WITH PULMONARY-HYPERTENSION
    WONG, J
    VANDERFORD, PA
    WINTERS, J
    SOIFER, SJ
    FINEMAN, JR
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1995, 25 (02) : 207 - 215
  • [40] Development of Angiotensin II Type 2 Receptor Agonists 'ATRAGs' for Treatment of Pulmonary Fibrosis and Pulmonary Hypertension
    Batta, R.
    Raud, J.
    Tornling, G.
    Nygard, M.
    Dalsgaard, C.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207